Lohidasan Sathiyanarayanan

Dr. Lohidasan Sathiyanarayanan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
PMPiyush Pradeep Mehta
Piyush Pradeep Mehta
RSRishi Shah
Rishi Shah
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan
KMK.R. Mahadik
K.R. Mahadik
Herbal medicine, the backbone of traditional medicine, has played an important role in human health and welfare for a long period. Traditional therapeutic approaches of regional significance are found in Africa, South and Central America, China, India, Tibet, Indonesia, and the Pacific Islands. The considerable scientific significance and commercial potential of traditional medicines have resulted in increased international attention and global market demands for herbal medicines, especially Chinese herbal medicines. Herbal medicines currently are the primary form of health care for the poor in the developing countries, and also are widely used as a supplement or substitute for conventional drugs in developed countries. These traditional medicines have a pivotal role in the treatment of various ailments and more than 50% of drugs used in Western pharmacopoeia are isolated from herbs or derived from modifications of chemicals found in plants. Herbal medicines usually contain a complex mixture of various bioactive molecules, which make its standardization complicated, and there is little information about all compounds responsible for pharmacological activity. Several research papers have been published that claim pharmacological activity of herbal medicines but few are discussing the role of the exact phytoconstituent. Understanding the pharmacokinetic profile of such phytoconstituents is essential. Although there are research papers that deal with pharmacokinetic properties of phytoconstituents, there are a number of phytoconstituents yet to be explored for their kinetic properties. This article reviews the pharmacokinetic profile of 50 different therapeutically effective traditional medicinal plants from the year 2003 onward.

1 September 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SNSadhana Nanaware
Sadhana Nanaware
MSMadhuri Shelar
Madhuri Shelar
ASArulmozhi Sinnathambi
Arulmozhi Sinnathambi
KMK.R. Mahadik
K.R. Mahadik
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan

1 April 2019 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
HKHarshad S Kapare
Harshad S Kapare
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan
ASArulmozhi Sinnathambi
Arulmozhi Sinnathambi
KMKakasaheb Mahadik
Kakasaheb Mahadik
Propolis from apiculture is known for wide range of medicinal properties owing to its vast chemical constituents including polyphenols, flavonoids and anticancer agent Caffeic acid phenethyl ester (CAPE). The objective of the study was to extract and standardize Indian propolis (IP) with respect to selected markers by newly developed High performance liquid chromatography (HPLC) method, to evaluate in vitro and in vivo anticancer activity and biosafety of Indian propolis. IP was extracted, optimized and standardized using a newly developed and validated HPLC method for simultaneous estimation of caffeic acid, apigenin, quercetin and CAPE. The standardised ethanolic extract of IP (EEIP) was screened for in vitro cytotoxicity using sulforhodamine B (SRB) assay, in vivo anti-carcinogenic effect against Dalton's Lymphoma ascites (DLA) cells, hemolytic effect and pesticide analysis. The EEIP was found to contain more amount of total flavonoids (23.61 ± 0.0452 mg equivalent of quercetin/g), total polyphenolics (34.82 ± 0.0785 mg equivalent of gallic acid/g) and all selected markers except caffeic acid compared to all other extracts. EEIP showed better anti-cancer potential than CAPE on MCF-7 and HT-29 cell line and significant (p < 0.01) in vivo anti-carcinogenic effects against DLA in comparison with 5-fluorouracil. EEIP was found to be non-hemolytic. From in vitro cytotoxicity, in vivo anti-carcinogenicity and biosafety studies it can be concluded that the standardized EEIP is safe and can be considered for further development as a biomedicine.

1 May 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ABAishwarya Balap
Aishwarya Balap
BABhagyashri Atre
Bhagyashri Atre
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan
ASArulmozhi Sinnathambi
Arulmozhi Sinnathambi
KMKakasaheb Mahadik
Kakasaheb Mahadik

1 June 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MSMadhuri Shelar
Madhuri Shelar
SNSadhana Nanaware
Sadhana Nanaware
SAS. Arulmozhi
S. Arulmozhi
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan
KMKakasaheb Mahadik
Kakasaheb Mahadik

7 September 2017 in Advances in Traditional Medicine
Verified
Journal Article
Closed access
PDF file
PMPiyush Pradeep Mehta
Piyush Pradeep Mehta
LSLohidasan Sathiyanarayanan
Lohidasan Sathiyanarayanan
KMK. R. Mahadik
K. R. Mahadik